These efforts include the development of the AD Diagnostic Kit WO2002/088706, which uses glutamine synthetase as an index, and WO2010/144634, which diagnoses AD by confirming the degree of DNA methylation as an epigenetic marker. Here, GLUL is linked to Alzheimer disease.